The fact that CD8+ T cells were both enriched and clonally expanded in the BRCA1 mutation carriers suggests that there is an early adaptive immune response among the FTE cells in patients with a BRCA1 mutation, even before the development of cancer. Here, BRCA1 is linked to cancer.